Publications by authors named "Mark Stolar"

Claim this Profile
S
SGLT2-inhibitors and asthma outcomes in type 2 diabetes: Insights from a large multicenter study.
A B M Nasibul Alam, Natasha Gill, Maram AlAshoor, Iman Cherif, Mark Stolar

Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COVID-19-Induced Diabetic Ketoacidosis in an Adult with Latent Autoimmune Diabetes.
Yetunde B Omotosho, Grace W Ying, Mark Stolar, Arvin Junn P Mallari

Cureus· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of extended release GLP-1 receptor agonist therapy versus sitagliptin in the management of type 2 diabetes.
Mark W Stolar, Michael Grimm, Steve Chen

Diabetes Metab Syndr Obes· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing cardiovascular risk in patients with type 2 diabetes: focus on primary care.
Mark Stolar

Am J Med Sci· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining and achieving treatment success in patients with type 2 diabetes mellitus.
Mark W Stolar

Mayo Clin Proc· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges.
James R Gavin, Mark W Stolar, Jeffrey S Freeman, Craig W Spellman

J Am Osteopath Assoc· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic control and complications in type 2 diabetes mellitus.
Mark Stolar

Am J Med· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Managing type 2 diabetes: going beyond glycemic control.
Mark W Stolar, Byron J Hoogwerf, Stephen M Gorshow, Patrick J Boyle, Dirk O Wales

J Manag Care Pharm· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic syndrome: controversial but useful.
Mark Stolar

Cleve Clin J Med· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes, cardiovascular risk, and the link to insulin resistance.
Mark W Stolar, Robert J Chilton

Clin Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin resistance, diabetes, and the adipocyte.
Mark W Stolar

Am J Health Syst Pharm· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis